Naver invests in clinical trial platform JNPMedi...expanding into healthcare and taking on global markets - WowTale
Summary
Naver invested in clinical-trial platform J&P Medi to expand its healthcare footprint and pursue global growth. J&P Medi offers a clinical trial platform for sponsors and CROs, including EMR-based smart surveys and AI-driven patient summaries. The company uses AI to improve patient recruitment, data collection, and trial reporting, and aims to scale internationally. Naver's investment will accelerate integration of AI-powered healthcare services and support J&P Medi's life-sciences software expansion.
Funding
Amount
-
Total raised
Date
August 13, 2025
Announcement date
Investors
-
Lead investors
Company
https://www.jnpmedi.com
Funded company
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
Clinical Trial Software
SaaS
Data Management Software
Linked Companies
JNPMEDI
$5M to $10M